CEPI (Coalition for Epidemic Preparedness Innovations)
Arun Kumar PhD, SCPM, serves as the RNA Innovation Programs Leader at the Coalition for Epidemic Preparedness Innovations (CEPI) since September 2018, focusing on the development of RNA-based vaccines to tackle significant public health issues. With a strong background in vaccine development, Arun has held roles at GSK as a Scientist I and Marie-Curie Scientist, working on self-amplifying mRNA technology for universal influenza vaccines and managing messenger RNA vaccine projects. Prior experience includes positions at Novartis Vaccines and Diagnostics and the University of Helsinki, where Arun specialized in novel SAM® vaccine platforms and studied immunological mechanisms of emerging viruses, respectively. Educational qualifications include a PhD in Viral Immunology from the University of Helsinki and certification as a Stanford Certified Project Manager.